With Dr. Vibeke Manniche, MD PhD. Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine (2023).
This research from Denmark work is only funded by crowd funding, via this link,
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden
2023, Nationwide study from Denmark
Identified a batch-dependent safety signal for the BNT162b2 mRNA COVID-19 vaccine
2024, Suspected adverse events (SAEs) Denmark and Sweden
SAEs reported to national authorities